The size of the Pharmaceutical Excipients Market in Europe was worth USD 2.15 billion in 2021 and is estimated to be growing at a CAGR of 5.92% to reach USD 2.87 billion by 2026. An excipient is a natural or synthetic constituent formulated alongside the active ingredient, included to induce and catalyze a wide range of physical and chemical properties. Pharmaceutical Excipients are substances that are involved in manufacturing processes and facilitate the use of medicines. Pharmaceutical Excipients include Gelatin, Cellulose, PVP, Starch, Sucrose, Polyethylene Glycol, etc.
Increasing incidences of chronic diseases due to a sedentary lifestyle, hefty investments by the pharmaceutical companies in the development of medicines, and implementing new novelties like nanotechnology are the market's major driving forces. However, decreasing the side-effects of drugs and developing environmentally friendly manufacturing processes are the significant challenges faced by the pharmaceutical industry.
Proper expansion strategies and launching a new product pipeline would be a lucrative opportunity for companies operating in this industry. Still, the market's growth is stalled to a certain level by the fact that investments in R & D by major companies are not up to the required. Increasing standard regulatory requirements makes it increasingly hard to get new manufacturing facilities approved, which are definite threats to overcome.
This research report segmented and sub-segmented into the following categories:
Regionally, the European market is in congruence with North America and occupies most of the share in the global market, accounting for almost 1/3 of the revenue. Despite that, growth is hindered here due to the maturity of the market. Emerging players in this market are giving stiff competition to the top 10 players who occupy more than 2/3 of the total market. It can be attributed to the rapid growth of the market and its opportunities in developing countries.
The European pharmaceutical excipients market development includes innovative methods to introduce new Excipients in the pharma business market, expand interests for medication, and drive the Pharmaceutical Excipient market. European countries' governments are funding heavily in the pharmaceutical market research activities, and these open doors for this market to grow. Europe is estimated to have the highest market share due to several large pharmaceutical and production capacities. The appearance of this substantial pharmaceutical area in European countries will require high consumption of Excipients, and the growing importance of pharmaceutical products, generics, and biosimilars are increasing demand for Excipients. Rising occurrences of vulnerable diseases generate new drugs and discoveries in the market. Excipients are hence much needed to fill up the medication in a large amount. MHRA (Medicines and Healthcare products Regulatory Agency), FDA (Food and Drug Administration), TGA (Therapeutic Goods Administration) examines the orders by assembling experts who influence the growing pharmaceutical Excipients market.
Being highly populated among European countries, Russia has a diverse range of market values for the Pharmaceutical Excipient market. The technological advancements are also helping to discover new entities for medications. Switzerland also has the oldest markets for pharmaceuticals and materials used for it. For Instance, IMPAG, independent international trading and service group based in Switzerland, has subsidiaries in Germany, Poland, France, Austria, provides raw materials, Excipients, and Additives from more than 90 Years.
Key players operating in the Europe Pharmaceutical Excipients Market profiled in this report are Ashland Inc., AkzoNobel, Archer Daniels Midland Company, Associated British Foods PLC, BASF SE, Colorcon, Inc., Croda International PLC, Evonik Industries AG, FMC Corporation, Innophos Holdings Inc., J.M. Huber Corporation, Merck Millipore, Roquette Group, The DOW Chemical Company and Lubrizol Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Organic Chemicals
5.1.1.1 Oleochemicals
5.1.1.2 Carbohydrates
5.1.1.3 Petrochemicals
5.1.1.4 Proteins
5.1.1.5 Other Organic Chemicals
5.1.2 Inorganic Chemicals
5.2.1.1 Calcium Phosphates
5.2.1.2 Metal Oxides
5.2.1.3 Halites
5.2.1.4 Calcium Carbonates
5.2.1.5 Calcium Sulfates
5.2.1.6 Other Inorganic Chemicals
5.2 By Functionality
5.2.1 Fillers & Diluents
5.2.2 Binders
5.2.3 Suspension & Viscosity Agents
5.2.4 Coatings
5.2.5 Disintegrants
5.2.6 Flavoring Agents
5.2.7 Lubricants & Glidants
5.2.8 Colorants
5.2.9 Preservatives
5.2.10 Other Functionalities
5.3 By Formulation Type
5.3.1 Oral Formulations
5.3.1.1 Tablets
5.3.1.2 Capsules
5.3.1.3 Liquid Formulations
5.3.2 Topical Formulations
5.3.3 Parenteral Formulations
5.3.4 Advanced Delivery Systems
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Ashland Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AkzoNobel
8.3 Archer Daniels Midland Company
8.4 Associated British Foods PLC
8.5 BASF SE,
8.6 Colorcon, Inc.
8.7 Croda International PLC
8.8 Evonik Industries AG
8.9 FMC Corporation
8.1 Innophos Holdings Inc.,
8.11 J.M. Huber Corporation
8.12 Merck Millipore
8.13 Roquette Group
8.14 The DOW Chemical Company
8.15 The Lubrizol Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
